Latest / Decera Clinical Education Oncology Podcast
Optimizing Bispecific Antibody Safety and Care Coordination From the Pharmacy in RRMM
In this episode, Dr Sara Ann Scott and Dr Syeda Saba Kareem discuss toxicities and the safe management of bispecific antibodies used in the treatment of RRMM to improve outcomes for patients, including:
The incidence of cytokine release syndrome (CRS), along with the grading system, treatment strategies, and the role of tocilizumab
Neurologic toxicities like the clinical manifestation of ICANS and the ICE scoring system used to help assign grading and appropriate treatment with dexamethasone, levetiracetam, and/or high-dose methylprednisolone
Infection susceptibilities associated with…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.